Evaluation of hs-CRP and sLOX-1 Levels in Moderate-to-High Risk Acute Coronary Syndromes

Author(s): Ali Çoner*, Alp Aydınalp, Haldun Müderrisoğlu.

Journal Name: Endocrine, Metabolic & Immune Disorders - Drug Targets
(Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders)

Volume 20 , Issue 1 , 2020

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Objective: Risk stratification and prompt treatment are essential for the management of acute coronary syndromes (ACS) and prediction of future prognosis. Subclinical vascular inflammation and novel biomarkers play an important role in the clinical evaluation of ACS patients.

Methods: We enrolled patients who were admitted to emergency service with unstable angina or non- ST segment elevated ACS (NSTE-ACS) in the study population. Coronary artery disease (CAD) complexity was determined via evaluation of angiographical views and peripheral venous blood samples were collected to measure highly sensitive C-reactive protein (hs-CRP) and soluble form of Lectin-like OxLDL receptor-1 (sLOX-1) levels.

Results: A total of 40 patients were enrolled in the study population, mean age was 65.1±13.8 years and male gender percentage was 52.5%. Twenty-nine of patients had NSTE-ACS and 11 patients had unstable angina presentation. The modified Gensini scores were higher for patients with elevated hs- CRP and sLOX-1 levels.

Conclusion: Vascular inflammation displays the onset of ACS and it is related to more complex CAD in these patients. An increase in sLOX-1 expression is closely related to anatomical complexity of CAD in ACS.

Keywords: Vascular inflammation, atherosclerotic plaque burden, acute coronary syndromes, risk stratification, hs-CRP, Lectin-like OxLDL receptor-1.

[1]
Gaziano, T.A.; Prabhakaran, D.; Gaziano, J.M. Global Burden of Cardiovascular Disease.Braunwald’s Heart Disease, A Textbook of Cardiovascular Medicine., 2015, Vol. 10, 1-20.
[2]
Lozano, R.; Naghavi, M.; Foreman, K.; Lim, S.; Shibuya, K.; Aboyans, V.; Abraham, J.; Adair, T.; Aggarwal, R.; Ahn, S.Y.; Alvarado, M.; Anderson, H.R.; Anderson, L.M.; Andrews, K.G.; Atkinson, C.; Baddour, L.M.; Barker-Collo, S.; Bartels, D.H.; Bell, M.L.; Benjamin, E.J.; Bennett, D.; Bhalla, K.; Bikbov, B.; Bin Abdulhak, A.; Birbeck, G.; Blyth, F.; Bolliger, I.; Boufous, S.; Bucello, C.; Burch, M.; Burney, P.; Carapetis, J.; Chen, H.; Chou, D.; Chugh, S.S.; Coffeng, L.E.; Colan, S.D.; Colquhoun, S.; Colson, K.E.; Condon, J.; Connor, M.D.; Cooper, L.T.; Corriere, M.; Cortinovis, M.; de Vaccaro, K.C.; Couser, W.; Cowie, B.C.; Criqui, M.H.; Cross, M.; Dabhadkar, K.C.; Dahodwala, N.; De Leo, D.; Degenhardt, L.; Delossantos, A.; Denenberg, J.; Des Jarlais, D.C.; Dharmaratne, S.D.; Dorsey, E.R.; Driscoll, T.; Duber, H.; Ebel, B.; Erwin, P.J.; Espindola, P.; Ezzati, M.; Feigin, V.; Flaxman, A.D.; Forouzanfar, M.H.; Fowkes, F.G.; Franklin, R.; Fransen, M.; Freeman, M.K.; Gabriel, S.E.; Gakidou, E.; Gaspari, F.; Gillum, R.F.; Gonzalez-Medina, D.; Halasa, Y.A.; Haring, D.; Harrison, J.E.; Havmoeller, R.; Hay, R.J.; Hoen, B.; Hotez, P.J.; Hoy, D.; Jacobsen, K.H.; James, S.L.; Jasrasaria, R.; Jayaraman, S.; Johns, N.; Karthikeyan, G.; Kassebaum, N.; Keren, A.; Khoo, J.P.; Knowlton, L.M.; Kobusingye, O.; Koranteng, A.; Krishnamurthi, R.; Lipnick, M.; Lipshultz, S.E.; Ohno, S.L.; Mabweijano, J.; MacIntyre, M.F.; Mallinger, L.; March, L.; Marks, G.B.; Marks, R.; Matsumori, A.; Matzopoulos, R.; Mayosi, B.M.; McAnulty, J.H.; McDermott, M.M.; McGrath, J.; Mensah, G.A.; Merriman, T.R.; Michaud, C.; Miller, M.; Miller, T.R.; Mock, C.; Mocumbi, A.O.; Mokdad, A.A.; Moran, A.; Mulholland, K.; Nair, M.N.; Naldi, L.; Narayan, K.M.; Nasseri, K.; Norman, P.; O’Donnell, M.; Omer, S.B.; Ortblad, K.; Osborne, R.; Ozgediz, D.; Pahari, B.; Pandian, J.D.; Rivero, A.P.; Padilla, R.P.; Perez-Ruiz, F.; Perico, N.; Phillips, D.; Pierce, K.; Pope, C.A., III; Porrini, E.; Pourmalek, F.; Raju, M.; Ranganathan, D.; Rehm, J.T.; Rein, D.B.; Remuzzi, G.; Rivara, F.P.; Roberts, T.; De León, F.R.; Rosenfeld, L.C.; Rushton, L.; Sacco, R.L.; Salomon, J.A.; Sampson, U.; Sanman, E.; Schwebel, D.C.; Segui-Gomez, M.; Shepard, D.S.; Singh, D.; Singleton, J.; Sliwa, K.; Smith, E.; Steer, A.; Taylor, J.A.; Thomas, B.; Tleyjeh, I.M.; Towbin, J.A.; Truelsen, T.; Undurraga, E.A.; Venketasubramanian, N.; Vijayakumar, L.; Vos, T.; Wagner, G.R.; Wang, M.; Wang, W.; Watt, K.; Weinstock, M.A.; Weintraub, R.; Wilkinson, J.D.; Woolf, A.D.; Wulf, S.; Yeh, P.H.; Yip, P.; Zabetian, A.; Zheng, Z.J.; Lopez, A.D.; Murray, C.J.; AlMazroa, M.A.; Memish, Z.A. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 2012, 380(9859), 2095-2128.
[http://dx.doi.org/10.1016/S0140-6736(12)61728-0] [PMID: 23245604]
[3]
Zamani, P.; Schwartz, G.G.; Olsson, A.G.; Rifai, N.; Bao, W.; Libby, P.; Ganz, P.; Kinlay, S. Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study. J. Am. Heart Assoc., 2013, 2(1)e003103
[http://dx.doi.org/10.1161/JAHA.112.003103] [PMID: 23525424]
[4]
Greco, T.P.; Conti-Kelly, A.M.; Anthony, J.R.; Greco, T., Jr; Doyle, R.; Boisen, M.; Kojima, K.; Matsuura, E.; Lopez, L.R. Oxidized-LDL/beta(2)-glycoprotein I complexes are associated with disease severity and increased risk for adverse outcomes in patients with acute coronary syndromes. Am. J. Clin. Pathol., 2010, 133(5), 737-743.
[http://dx.doi.org/10.1309/AJCP88WVRDRDFBAS] [PMID: 20395520]
[5]
Acet, H.; Ertaş, F.; Bilik, M.Z.; Aydın, M.; Yüksel, M.; Polat, N.; Yıldız, A.; Özyurtlu, F.; Akıl, M.A.; Çiftçi, L.; Özbek, M.; Alan, S.; Toprak, N. The relationship of TIMI risk index with SYNTAX and Gensini risk scores in predicting the extent and severity of coronary artery disease in patients with STEMI undergoing primary percutaneous coronary intervention. Ther. Adv. Cardiovasc. Dis., 2015, 9(5), 257-266.
[http://dx.doi.org/10.1177/1753944715574814] [PMID: 25784498]
[6]
Bekler, A.; Altun, B.; Gazi, E.; Temiz, A.; Barutçu, A.; Güngör, Ö.; Özkan, M.T.; Özcan, S.; Gazi, S.; Kırılmaz, B. Comparison of the GRACE risk score and the TIMI risk index in predicting the extent and severity of coronary artery disease in patients with acute coronary syndrome. Anatol. J. Cardiol., 2015, 15(10), 801-806.
[http://dx.doi.org/10.5152/akd.2014.5802] [PMID: 25592101]
[7]
Roy, S.S.; Abu Azam, S.T.M.; Khalequzzaman, M.; Ullah, M.; Arifur Rahman, M. GRACE and TIMI risk scores in predicting the angiographic severity of non-ST elevation acute coronary syndrome. Indian Heart J., 2018, 70(Suppl. 3), S250-S253.
[http://dx.doi.org/10.1016/j.ihj.2018.01.026] [PMID: 30595268]
[8]
Yusufali, A.; Zubaid, M.; Al-Zakwani, I.; Alsheikh-Ali, A.A.; Al-Mallah, M.H.; Al Suwaidi, J.; AlMahmeed, W.; Rashed, W.; Sulaiman, K.; Amin, H. Validation of the GRACE Risk score for hospital mortality in patients with acute coronary syndrome in the Arab Middle East. Angiology, 2011, 62(5), 390-396.
[http://dx.doi.org/10.1177/0003319710387921] [PMID: 21307002]
[9]
Fox, K.A.; Dabbous, O.H.; Goldberg, R.J.; Pieper, K.S.; Eagle, K.A.; Van de Werf, F.; Avezum, A.; Goodman, S.G.; Flather, M.D.; Anderson, F.A., Jr; Granger, C.B. Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ, 2006, 333(7578), 1091-1096.
[http://dx.doi.org/10.1136/bmj.38985.646481.55] [PMID: 17032691]
[10]
Kurtoğlu Gümüşel, H.; Çatakoğlu, A.B.; Yıldırımtürk, Ö.; Yurdakul, S.; Helvacıoğlu, F.; Ziyrek, M.; Hanavdeloğulları, R.; Aytekin, V.; Aytekin, S. Relationship between endothelial dysfunction and cardiovascular risk factors and the extent and severity of coronary artery disease. Turk Kardiyol. Dern. Ars., 2014, 42(5), 435-443.
[http://dx.doi.org/10.5543/tkda.2014.72798] [PMID: 25080949]
[11]
Khandelwal, G.; Jain, A.; Rathore, M. Prediction of angiographic extent of coronary artery disease on the basis of clinical risk scores in patients of unstable angina. J. Clin. Diagn. Res., 2015, 9(11), OC13-OC16.
[http://dx.doi.org/10.7860/JCDR/2015/15069.6778] [PMID: 26672410]
[12]
Libby, P. Mechanisms of acute coronary syndromes and their implications for therapy. N. Engl. J. Med., 2013, 368(21), 2004-2013.
[http://dx.doi.org/10.1056/NEJMra1216063] [PMID: 23697515]
[13]
Sinning, C.; Lillpopp, L.; Appelbaum, S.; Ojeda, F.; Zeller, T.; Schnabel, R.; Lubos, E.; Jagodzinski, A.; Keller, T.; Munzel, T.; Bickel, C.; Blankenberg, S. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin. Res. Cardiol., 2013, 102(7), 495-503.
[http://dx.doi.org/10.1007/s00392-013-0555-4] [PMID: 23519584]
[14]
Zencirci, A.E.; Zencirci, E.; Degirmencioglu, A.; Karakus, G.; Ugurlucan, M.; Gunduz, S.; Ozden, K.; Erdem, A.; Karadeniz, F.; Ekmekci, A.; Erer, H.; Sayar, N.; Eren, M. The relationship between Gensini score and ST-segment resolution in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kardiol. Pol., 2014, 72(6), 494-503.
[http://dx.doi.org/10.5603/KP.a2013.0355] [PMID: 24408069]
[15]
Kadzhaia, G.V. [Fluctuation of C-reactive protein levels in acute coronary syndrome] Georgian Med. News, 2005, (128), 41-44. [Fluctuation of C-reactive protein levels in acute coronary syndrome]
[PMID: 16369062]
[16]
Kiliç, T.; Ural, E.; Oner, G.; Sahin, T.; Kiliç, M.; Yavuz, S.; Kanko, M.; Kahraman, G.; Bildirici, U.; Berki, K.T.; Ural, D. [Which cut-off value of high sensitivity C- reactive protein is more valuable for determining long- term prognosis in patients with acute coronary syndrome?] Anadolu Kardiyol. Derg., 2009, 9(4), 280-289. [Which cut-off value of high sensitivity C-reactive protein is more valuable for determining long-term prognosis in patients with acute coronary syndrome?]
[PMID: 19666429]
[17]
Karacaglar, E.; Atar, I.; Altin, C.; Yetis, B.; Cakmak, A.; Bayraktar, N.; Coner, A.; Ozin, B.; Muderrisoglu, H. The effects of niacin on inflammation in patients with non-ST elevated acute coronary syndrome. Acta. Acta Cardiol Sin, 2015, 31(2), 120-126.
[PMID: 27122858]
[18]
Karadeniz, M.; Duran, M.; Akyel, A.; Yarlıoğlueş, M.; Öcek, A.H.; Çelik, İ.E.; Kılıç, A.; Yalcin, A.A.; Ergün, G.; Murat, S.N. High sensitivity CRP level is associated with intermediate and high syntax score in patients with acute coronary syndrome. Int. Heart J., 2015, 56(4), 377-380.
[http://dx.doi.org/10.1536/ihj.14-299] [PMID: 26118590]
[19]
Ticinesi, A.; Lauretani, F.; Nouvenne, A.; Porro, E.; Fanelli, G.; Maggio, M.; Meschi, T. C-reactive protein (CRP) measurement in geriatric patients hospitalized for acute infection. Eur. J. Intern. Med., 2017, 37, 7-12.
[http://dx.doi.org/10.1016/j.ejim.2016.08.026] [PMID: 27594414]
[20]
Shrivastava, A.K.; Singh, H.V.; Raizada, A.; Singh, S.K.; Pandey, A.; Singh, N.; Yadav, D.S.; Sharma, H. Inflammatory markers in patients with rheumatoid arthritis. Allergol. Immunopathol. (Madr.), 2015, 43(1), 81-87.
[http://dx.doi.org/10.1016/j.aller.2013.11.003] [PMID: 24656623]
[21]
Umare, V.; Nadkarni, A.; Nadkar, M.; Rajadhyksha, A.; Khadilkar, P.; Ghosh, K.; Pradhan, V.D. Do high sensitivity C-reactive protein and serum interleukin-6 levels correlate with disease activity in systemic lupus erythematosuspatients? J. Postgrad. Med., 2017, 63(2), 92-95.
[http://dx.doi.org/10.4103/0022-3859.188550] [PMID: 27531690]
[22]
Mehta, J.L. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein in atherosclerosis. Can. J. Cardiol., 2004, 20(Suppl. B), 32-36.
[23]
Berliner, J.A.; Territo, M.C.; Sevanian, A.; Ramin, S.; Kim, J.A.; Bamshad, B.; Esterson, M.; Fogelman, A.M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest., 1990, 85(4), 1260-1266.
[http://dx.doi.org/10.1172/JCI114562] [PMID: 2318980]
[24]
Reid, V.C.; Mitchinson, M.J. Toxicity of oxidised low density lipoprotein towards mouse peritoneal macrophages in vitro. Atherosclerosis, 1993, 98(1), 17-24.
[http://dx.doi.org/10.1016/0021-9150(93)90219-K] [PMID: 8457247]
[25]
Steinbrecher, U.P. Receptors for oxidized low density lipoprotein. Biochim. Biophys. Acta, 1999, 1436(3), 279-298.
[http://dx.doi.org/10.1016/S0005-2760(98)00127-1] [PMID: 9989260]
[26]
Sawamura, T.; Kume, N.; Aoyama, T.; Moriwaki, H.; Hoshikawa, H.; Aiba, Y.; Tanaka, T.; Miwa, S.; Katsura, Y.; Kita, T.; Masaki, T. An endothelial receptor for oxidized low-density lipoprotein. Nature, 1997, 386(6620), 73-77.
[http://dx.doi.org/10.1038/386073a0] [PMID: 9052782]
[27]
Kattoor, A.J.; Kanuri, S.H.; Mehta, J.L. Role of Ox-LDL and LOX-1 in atherogenesis. Curr. Med. Chem., 2018. Epub ahead of print
[http://dx.doi.org/10.2174/0929867325666180508100950] [PMID: 29737246]
[28]
Ohki, I.; Ishigaki, T.; Oyama, T.; Matsunaga, S.; Xie, Q.; Ohnishi-Kameyama, M.; Murata, T.; Tsuchiya, D.; Machida, S.; Morikawa, K.; Tate, S. Crystal structure of human lectin-like, oxidized low-density lipoprotein receptor 1 ligand binding domain and its ligand recognition mode to OxLDL. Structure, 2005, 13(6), 905-917.
[http://dx.doi.org/10.1016/j.str.2005.03.016] [PMID: 15939022]
[29]
Li, D.; Mehta, J.L. Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte adhesion to human coronary artery endothelial cells. Circulation, 2000, 101(25), 2889-2895.
[http://dx.doi.org/10.1161/01.CIR.101.25.2889] [PMID: 10869259]
[30]
Kataoka, H.; Kume, N.; Miyamoto, S.; Minami, M.; Moriwaki, H.; Murase, T.; Sawamura, T.; Masaki, T.; Hashimoto, N.; Kita, T. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation, 1999, 99(24), 3110-3117.
[http://dx.doi.org/10.1161/01.CIR.99.24.3110] [PMID: 10377073]
[31]
Hayashida, K.; Kume, N.; Murase, T.; Minami, M.; Nakagawa, D.; Inada, T.; Tanaka, M.; Ueda, A.; Kominami, G.; Kambara, H.; Kimura, T.; Kita, T. Serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are elevated in acute coronary syndrome: a novel marker for early diagnosis. Circulation, 2005, 112(6), 812-818.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.104.468397] [PMID: 16061745]
[32]
Tian, K.; Ogura, S.; Little, P.J.; Xu, S.W.; Sawamura, T. Targeting LOX-1 in atherosclerosis and vasculopathy: current knowledge and future perspectives. Ann. N. Y. Acad. Sci., 2018. Epub ahead of print
[http://dx.doi.org/10.1111/nyas.13984] [PMID: 30381837]
[33]
Kume, N.; Mitsuoka, H.; Hayashida, K.; Tanaka, M.; Kita, T. Soluble lectin-like oxidized low-density lipoprotein receptor-1 predicts prognosis after acute coronary syndrome--a pilot study. Circ. J., 2010, 74(7), 1399-1404.
[http://dx.doi.org/10.1253/circj.CJ-09-0924] [PMID: 20467154]
[34]
Kobayashi, N.; Hata, N.; Kume, N.; Seino, Y.; Inami, T.; Yokoyama, S.; Shinada, T.; Tomita, K.; Kaneshige, T.; Mizuno, K. Soluble lectin-like oxidized low-density lipoprotein receptor-1 as an early biomarker for ST elevation myocardial infarction: time-dependent comparison with other biomarkers: time-dependent comparison with other biomarkers. Circ. J., 2011, 75(6), 1433-1439.
[http://dx.doi.org/10.1253/circj.CJ-10-0913] [PMID: 21467660]
[35]
Kobayashi, N.; Hata, N.; Takahashi, Y.; Shinada, T.; Tomita, K.; Mizuno, K. A case of myocardial infarction caused by coronary vasospasm: efficacy of soluble lectin-like oxidized LDL receptor-1 for distinguishing between vasospasm and plaque rupture. J. Nippon Med. Sch., 2009, 76(5), 268-271.
[http://dx.doi.org/10.1272/jnms.76.268] [PMID: 19915312]
[36]
Yokota, C.; Sawamura, T.; Watanabe, M.; Kokubo, Y.; Fujita, Y.; Kakino, A.; Nakai, M.; Toyoda, K.; Miyamoto, Y.; Minematsu, K. High levels of soluble lectin-like oxidized low-density lipoprotein receptor-1 in acute stroke: an age- and sex-matched cross-sectional study. J. Atheroscler. Thromb., 2016, 23(10), 1222-1226.
[http://dx.doi.org/10.5551/jat.32466] [PMID: 27025681]
[37]
Higuma, T.; Abe, N.; Tateyama, S.; Endo, T.; Shibutani, S.; Yokoyama, H.; Hanada, K.; Yamada, M.; Tomita, H.; Hanada, H.; Osanai, T.; Kume, N.; Okumura, K. Plasma soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel prognostic biomarker in patients with ST-segment elevation acute myocardial infarction. Circ. J., 2015, 79(3), 641-648.
[http://dx.doi.org/10.1253/circj.CJ-14-0904] [PMID: 25746549]
[38]
Mashayekhi, S.; Ziaee, M.; Garjani, A.; Sarbakhsh, P.; Ghaffari, S. Prognostic value of sLOX-1 level in acute coronary syndromes based on thrombolysis in myocardial infarction risk score and clinical outcome. J. Emerg. Med., 2018, 55(3), 390-398.
[http://dx.doi.org/10.1016/j.jemermed.2018.06.018] [PMID: 30049431]
[39]
Zhao, Z.W.; Zhu, X.L.; Luo, Y.K.; Lin, C.G.; Chen, L.L. Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with angiographic coronary lesion complexity in patients with coronary artery disease. Clin. Cardiol., 2011, 34(3), 172-177.
[http://dx.doi.org/10.1002/clc.20847] [PMID: 21400544]
[40]
Frodermann, V.; van Puijvelde, G.H.; Wierts, L.; Lagraauw, H.M.; Foks, A.C.; van Santbrink, P.J.; Bot, I.; Kuiper, J.; de Jager, S.C. Oxidized low-density lipoprotein-induced apoptotic dendritic cells as a novel therapy for atherosclerosis. J. Immunol., 2015, 194(5), 2208-2218.
[http://dx.doi.org/10.4049/jimmunol.1401843] [PMID: 25653425]
[41]
Pothineni, N.V.K.; Karathanasis, S.K.; Ding, Z.; Arulandu, A.; Varughese, K.I.; Mehta, J.L. LOX-1 in atherosclerosis and myocardial ischemia: biology, genetics, and modulation. J. Am. Coll. Cardiol., 2017, 69(22), 2759-2768.
[http://dx.doi.org/10.1016/j.jacc.2017.04.010] [PMID: 28571642]


Rights & PermissionsPrintExport Cite as


Article Details

VOLUME: 20
ISSUE: 1
Year: 2020
Page: [96 - 103]
Pages: 8
DOI: 10.2174/1871530319666190408145905
Price: $65

Article Metrics

PDF: 15
HTML: 2

Special-new-year-discount